Trial Profile
For individuals with schizophrenia and insomnia, can melatonin and CBT improve sleep, symptoms, functioning and cognitive functions
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 16 Feb 2021
Price :
$35
*
At a glance
- Drugs Melatonin (Primary)
- Indications Insomnia; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Acronyms SIPS
- 12 Feb 2021 Status changed from not yet recruiting to discontinued.
- 14 Oct 2013 New trial record